International
The Morning Science

What science found today

‹
 

Research2 sources

Two Tuberculosis Regimens Containing Novel Agents Show Promise

MedPage Today ·

Two Tuberculosis Regimens Containing Novel Agents Show Promise

The Brief · written from 2 sources

  • Two new 16-week tuberculosis regimens advanced in a clinical trial, according to reports dated 2026-11-19.
  • Both regimens are four-drug combinations that pair novel agents with commonly used drugs.
  • Results from a phase II trial suggested the regimens show promise and should be evaluated further.

Why it matters

Tuberculosis treatment is long and burdened by side effects, so shorter 16-week regimens with new agents could matter for patients and for TB drug development if later trials confirm the early results.

Who’s affected

  • tuberculosis patients and clinicians
  • researchers and drug developers working on TB treatment

(MedPage Today) -- Two four-drug regimens that combined new agents with commonly used drugs showed promise in tuberculosis (TB), and should be evaluated further, results from a phase II trial suggested. The time to positivity slope -- the rate...

Timeline

  1. Results of phase II trial of two four-drug tuberculosis regimens reported

  2. Medical Xpress - latest medical and health news stories

    Two new 16-week tuberculosis regimens advance in clinical trial

  3. MedPageToday.com - medical news for physicians

    Two Tuberculosis Regimens Containing Novel Agents Show Promise

Full coverage · 2 sources

How do you feel about this?

0 Comments

    Two Tuberculosis Regimens Containing Novel Agents Show Promise – The Morning Science